TGFB1 and head and neck squamous cell carcinoma: Similarly, genetic and epigenetic aberrations of the H-RAS, NOTCH, PI3K/Akt, BRCA1, and TGF-β pathways have also been associated with HNSCC, but targeted agents remain in preclinical stages for HNSCC (2).